Retraction: Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery (The European Journal of Contraception & Reproductive Health Care, (2013), 18, 4, (300-308), 10.3109/13625187.2013.800855);Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery

European Journal of Contraception and Reproductive Health Care

Volumn 18, Issue 4, 2013, Pages 300-308

  Ibrahim, Zakia Mahdy ^a   Ahmed, Waleed Ali Sayed ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Cervical priming; Contraception; Insertion of intrauterine device; Intrauterine device; Misoprostol; Pain

Indexed keywords

COPPER INTRAUTERINE DEVICE; DICLOFENAC POTASSIUM; MISOPROSTOL; MISOTAC; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ANALGESIA; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DIARRHEA; EGYPT; ELECTIVE SURGERY; FEMALE; FEVER; HEADACHE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; NAUSEA; OUTCOME ASSESSMENT; PARITY; PATIENT SATISFACTION; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIVERING; SIDE EFFECT; SINGLE BLIND PROCEDURE; VAGINAL DELIVERY; VOMITING;

EID: 84880309652     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625187.2024.2313930     Document Type: Erratum

References (25)

1. Farmer M , Webb A. Intrauterine device insertionrelated complications: Can they be predicted? J Fam Plann Reprod Health Care 2003;29:227-31. (Pubitemid 37271177)
2. Li YT , Kuo TC, Kuan LC, Chu YC. Cervical softening with vaginal misoprostol before intrauterine device insertion. Int J Gynaecol Obstet 2005;89:67-8. (Pubitemid 40381151)
3. Harper C C, Blum M, de Bocanegra HT, et al. Challenges in translating evidence to practice: The provision of intrauterine contraception. Obstet Gynecol 2008;111:1359-69.
4. Black K , Lotke P, Buhling K J, Zite NB and on behalf of the Intrauterine contraception for Nulliparous women: Translating Research into Action (INTRA) group. A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women. Eur J Contracept Reprod Health Care 2012;17:340-50.
5. Intrauterine device and adolescents. ACOG Committee Opinion No. 392. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:1493-5.
6. Kulier R, Gulmezoglu AM, Hofmeyr GJ, et al. Medical methods for fi rst trimester abortion. Cochrane Database Syst Rev 2004 (2):CD002855.
7. Fiala C, Gemzell-Danielsson K , Tang OS, von Hertzen H. Cervical priming with misoprostol prior to transcervical procedures. Int J Gynaecol Obstet 2007;99 (Suppl. 2):S168-71. (Pubitemid 350110439)
8. Association of Reproductive Health Professionals. A clinical update on intrauterine contraception. Accessed 4 March 2013 from: http://www.arhp.org/ modules/webinars/A-Clinical-Update-on-Intrauterine-Contraception-/1.
9. Kwee A , Bots ML, Visser GH, Bruinse HW. Obstetric management and outcome of pregnancy in women with a history of a cesarean section in the Netherlands. Eur J Obstet Gynecol Reprod Biol 2007;132:171-6. (Pubitemid 46830726)
10. Rothman K J. Epidemiology: An introduction. New York: Oxford University Press 2002:28-33.
11. Sä ä v I , Aronsson A, Marions L , et al. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: A randomized controlled trial. Hum Reprod 2007;22:2647-52. (Pubitemid 47434207)
12. Dijkhuizen K , Dekkers O M, Holleboom C A, et al. Vaginal misoprostol prior to insertion of an intrauterine device: An RCT. Hum Reprod 2011;26:323-9.
13. Scavuzzi M, Amorim M, Acioly D , et al. Misoprostol prior to insertion of intrauterine device in nullipara: A randomized controlled trial. A pilot study. Int J Gynaecol Obstet 2009;107 (Suppl. 2): S330.
14. Edelman AB , Schaefer E , Olson A, et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception 2011;84:234-9.
15. Heikinheimo O , Inki P , Kunz M , et al. Double-blind, randomized, placebo controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81:481-6.
16. Tang O S, Gemzell-Danielsson K , Ho P C. Misoprostol: Pharmacokinetic profi les, effects on the uterus and side effects. Int J Gynecol Obstet 2007;99:S160-7. (Pubitemid 350101541)
17. Aronsson A, Fiala C , Stephansson O , et al. Pharmacokinetic profi les up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol. Hum Reprod 2007;22:1912-8. (Pubitemid 47062759)
18. Aronsson A, Bygdeman M , Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 2004;19:81-4. (Pubitemid 38072011)
19. Fiala C, Swahn ML, Stephansson O , Gemzell-Danielsson K. The effect of non-steroidal anti-infl ammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation. Hum Reprod 2005;20:3072-7. (Pubitemid 41662658)
20. Li CF, Wong CY , Chan CP, Ho PC. A study of co-treatment of nonsteroidal anti-infl ammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of fi rst trimester pregnancy. Contraception 2003;67:101-5. (Pubitemid 36174009)
21. Grimes D. Intrauterine device and upper-genital tract infection. Lancet 2000;356:1013-9.
22. Vimala N , Mittal S , Kumar S. Sublingual misoprostol for preabortion cervical ripening in fi rst-trimester pregnancy termination. Contraception 2003;67:295-7. (Pubitemid 36398514)
23. Vimala N, Mittal S, Kumar S, et al. A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of fi rsttrimester pregnancy. Contraception 2004;70:117-20. (Pubitemid 38993487)
24. Singh K , Fong YF , Prasad RN, Dong F. Vaginal misoprostol for preabortion cervical priming: Is there an optimal evacuation time interval. Br J Obstet Gynaecol 1999;106:266-9. (Pubitemid 29118914)
25. Sharma S , Refaey H , Stafford M , et al. Oral versus vaginal misoprostol administered one hour before surgical termination of pregnancy: A randomized controlled trial. BJOG 2005;112:456-60. (Pubitemid 40516560)